Have a Claim?

Click here for a confidential contact or call:

1-347-417-2192

September 22, 2016

Posted  September 22, 2016

New York announced that, together with the Attorneys General of 34 other states and the District of Columbia, his office has filed a lawsuit against Indivior, the manufacturer of the branded drug Suboxone, and MonoSolRX, the company that licensed its patented sublingual film technology to Indivior. Suboxone is used to treat patients addicted to heroin and other drugs, including painkillers. The lawsuit alleges that Indivior (which was spun off from Reckitt Benckiser in 2014) tried to coerce patients to switch from a tablet to a dissolvable oral strip version of Suboxone and engaged in other anticompetitive business practices to maintain Indivior’s monopoly over Suboxone. NY